Valerie Reyna, the Lois and Melvin Tukman Professor of Human Development and co-director of the Center for Behavioral Economics and Decision Research, recently answered questions about workplace risk.
Cornell administrators announced that the university would be changing its COVID-19 alert level to yellow following an increase in the number of positive cases on campus.
FARVets, a nonprofit run through the College of Veterinary Medicine to address animal overpopulation with spay-neuter clinics and vaccinations, has extended its reach in New York state as it has had to limit international programming because of the COVID-19 pandemic.
Cornell researchers are working collaboratively at the forefront of their fields to re-examine and adapt their innovations to develop the tests, treatments and knowledge necessary to end the COVID-19 pandemic.
Women who receive COVID-19 mRNA vaccines produced by Pfizer-BioNTech or Moderna while in their third trimester of pregnancy generate a strong immune response and pass protective antibodies to their babies.
Tests to date of more than 4,000 students, faculty and staff show a very low prevalence of COVID-19 as Cornell prepares to test thousands of returning students.
A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.